Out-licensing

Innovative out-licensing products for pharma partners around the globe.

Excellence in advanced drug delivery and fully integrated services – everything from a single source, from us.

  • Excellent Swiss-quality products

    Everything from a single source, from us

  • Excellent Swiss-quality products

    Acino develops and manufactures high quality medicinal products with established active ingredients in advanced and refined drug delivery systems. We supply leading pharmaceutical and generics companies around the globe.

    Everything from a single source, from us

    We go beyond products and offer fully integrated services including drug regulatory services and product supply. We can support you, from sourcing of an active pharmaceutical ingredient to finished product.

Market-ready Licensing Products

Acino is a Swiss-based company that develops and manufactures high quality medicinal products with established active ingredients in advanced and refined drug delivery systems. New products are continually being developed and added to our extensive range.

The following products, which are either already marketed or in registration, are currently available for out-licensing:

Active ingredient Formulation Dosage strength
Acino assembles complete registration dossiers and offers for all products a Common Technical Document (CTD).
Alfuzosine
G04CA01
Retard tablet 5 / 10 mg
Amlodipine
C08CA01
Tablet 5 / 10 mg
Clopidogrel
B01AC04
Film tablet 75 mg
Doxazosine
C02CA04
Retard tablet 4 / 8 mg
Itraconazole
J02AC02
Capsule 100 mg
Metoprolol succinate
C07AB02
Once-daily retard tablet 23.75 / 47.5 / 95 / 190 mg
Nebivolol
AC07AB12
Tablet 5 mg
Oxycodone
N02AA05
Retard tablet 5 / 10 / 20 / 30 / 40 / 60 / 80 mg

On July 25, 2016, Acino International AG and Acino Pharma AG (together “Acino”) signed an agreement to divest Acino’s transdermal patch and implant business to Luye Pharma Group Ltd. (“Luye”). The divestment includes Acino’s transdermal manufacturing operations, distribution, and R&D capabilities. Closing of this deal is expected before the end of 2016.

Acino will retain the marketing rights to certain transdermal patches in its strategic emerging markets.

 

Disclaimer
Brand names/trademarks might be subject to local/regional adaption. Indication for use might differ due to local requirements/registration. Indications given in this table are based on the respective underlying CH or EU marketing authorizations.

Services

Acino offers fully integrated services. Whether you opt for the entire service chain or have individual needs, we provide top-quality work, something every customer can rightfully expect from us.

  • Sourcing

    Acino Sourcing Network

    Sourcing of APIs, excipients, packaging materials
     
    Worldwide networkensuring competitive costs and compliance

  • Development

    Acino Technology Competence And R&D Centers

    Development of solid oral forms
    acino

  • Registration

    Acino Regulatory Affairs Team

    Compilation of dossiers ready for submission worldwide

  • Manufacturing

    Acino Production Sites

    Manufacturing of finished dosage form

    Supply of bulk product

  • Packaging

    Acino Packaging Facilities

    Primary & secondary packaging

    Supply of finished product
    acino with customers

Regulatory Services

Our drug regulatory experts have a broad-based knowledge of the regulatory requirements for the different products and indications and know the local regulatory requirements around the globe inside out.

From early development, we provide regulatory advice throughout the commercial life of a product. We support contract partners in the provision of regulatory relevant documentation, ensure regulatory compliance for all products on the market and provide regulatory intelligence services.

Our specific expertise includes:

  • Design of regulatory strategies, starting from the inception of a new product idea
  • Provision and assembly of complete registration dossiers for all development and marketed products
  • Worldwide submission and registration

Product Supply

Different product characteristics and galenical forms require different packaging. Even more complex are the requirements of our customers when it comes to tailor-made product packaging, be it in bulk or medicine packaged in their final packaging for distribution to patients.

Managing the supply chain with a large variety of pack sizes, country-specific labeling and patient information in different languages is a well-established logistics task for our experienced team. Providing these services with the accustomed indisputable quality is a matter of course for our customers, and rounds off our service offering.

We package in numerous variations, the most widely used ones are:

  • bulk
  • blisters with foil (PP, Aclar, childproof foils, etc.) and alu-alu-blisters
  • alu-alu-strip packaging
  • sachets
  • stick packs

Our logistics facility for oral drugs in Aesch (Switzerland) is equipped with state-of-the-art packaging lines and a fully automated high bay warehouse with 8000 pallet racks.

Contacts

  • Out-Licensing

    Timo Taghizadeh

    Head of Out-Licensing and Contract Manufacturing
    Telefon +41 44 555 22 62
    Email

  • General enquiries

    Acino International AG

    Thurgauerstrasse 36/38
    CH-8050 Zurich
    Telefon +41 44 555 22 00
    Email